CureVac (CVAC) has reported its fourth quarter 2024 financial results, generating mixed reactions from investors as the company balances ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Cleveland Clinic virology researchers have found that a specific protein modification to the immune protein MDA5 is key to ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.